Abstract
We first used MucoUp®, a hyaluronic acid used in endoscopic resection, as a spacer in brachytherapy. In five cervical cancer patients, MucoUp® insertion increased a 90% dose of the high-risk CTV to over 80Gy while decreasing the dose of organs at risk. No related adverse events were observed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have